- Home
- AAPG vs INDV Comparison
AAPG vs INDV Comparison
Compare AAPG & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- INDV
- Stock Information
- Founded
- AAPG 2009
- INDV 1994
- Country
- AAPG China
- INDV United States
- Employees
- AAPG N/A
- INDV N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- AAPG Health Care
- INDV Health Care
- Exchange
- AAPG Nasdaq
- INDV Nasdaq
- Market Cap
- AAPG 3.6B
- INDV 3.1B
- IPO Year
- AAPG 2025
- INDV N/A
- Fundamental
- Price
- AAPG $34.61
- INDV $25.09
- Analyst Decision
- AAPG Buy
- INDV Strong Buy
- Analyst Count
- AAPG 1
- INDV 4
- Target Price
- AAPG N/A
- INDV $23.75
- AVG Volume (30 Days)
- AAPG 7.0K
- INDV 1.4M
- Earning Date
- AAPG 11-19-2025
- INDV 10-30-2025
- Dividend Yield
- AAPG N/A
- INDV N/A
- EPS Growth
- AAPG N/A
- INDV N/A
- EPS
- AAPG N/A
- INDV 0.42
- Revenue
- AAPG $54,524,554.00
- INDV $1,173,000,000.00
- Revenue This Year
- AAPG N/A
- INDV N/A
- Revenue Next Year
- AAPG $368.64
- INDV $3.00
- P/E Ratio
- AAPG N/A
- INDV $60.36
- Revenue Growth
- AAPG N/A
- INDV 2.27
- 52 Week Low
- AAPG $16.50
- INDV $7.62
- 52 Week High
- AAPG $48.45
- INDV $25.49
- Technical
- Relative Strength Index (RSI)
- AAPG 39.44
- INDV 61.49
- Support Level
- AAPG $33.12
- INDV $23.72
- Resistance Level
- AAPG $35.49
- INDV $25.49
- Average True Range (ATR)
- AAPG 0.97
- INDV 0.77
- MACD
- AAPG -0.22
- INDV 0.07
- Stochastic Oscillator
- AAPG 20.89
- INDV 85.24
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.